| Completed | Bioequivalence Study to Compare Empagliflozin / Metformin 25 mg/ 1000 mg Extended-Release Tablet Versus Synjar Type 2 Diabetes Mellitus (T2DM) | Phase 1 | 2025-09-27 |
| Completed | Bioequivalence Study to Compare Vonoprazan 20 mg Film Coated Tablets Versus Voquezna® 20 mg (Vonoprazan) Table Erosive Gastritis, Erosive Esophagitis(EE), HELICOBACTER PYLORI INFECTIONS | Phase 1 | 2025-09-21 |
| Completed | Bioequivalence Study of Test Product (T) of Ertugliflozin/Metformin 7.5 mg/ 1000 mg Film Coated Tablets and Re Type 2 Diabetes | Phase 1 | 2025-08-22 |
| Completed | Bioequivalence Study to Compare Empagliflozin / Metformin 25 mg/ 1000 mg Extended-Release Tablet Versus Synjar Type 2 Diabetes Mellitus (T2DM) | Phase 1 | 2025-08-05 |
| Completed | Bioequivalence Study to Compare Brexpiprazole 4 mg Film Coated Tablets Versus RXULTI 4 mg Film Coated Tablet ( Schizophrenia | Phase 1 | 2025-06-22 |
| Completed | To Compare and Evaluate the Oral Bioavailability of Lisdexamfetamine 70 mg Capsule With That of Elvanse® 70 mg Attention Deficit/Hyperactivity Disorder (ADHD) | Phase 1 | 2025-05-26 |
| Completed | Bioequivalence Study of Bempedoic Acid 180 mg Film Coated Tablet and Nilemdo® (Bempedoic Acid) 180 mg Film-coa Hypercholesterolaemia | Phase 1 | 2025-05-21 |
| Completed | Bioequivalence Study to Compare Empagliflozin/Linagliptin/Metformin HCL 25mg/5mg/1000mg Extended-Release Table Type 2 Diabetes Mellitus (T2DM) | Phase 1 | 2025-05-21 |
| Completed | To Compare and Evaluate the Oral Bioavailability of Bilastine 20 mg Orally Dispersible Tablet With That of Bil Allergic Rhino-Conjunctivitis, Urticaria | Phase 1 | 2025-04-30 |
| Completed | To Compare and Evaluate the Oral Bioavailability of Empagliflozin + Linagliptin 10 mg/5 mg Filmcoated Tablets Type 2 Diabetes Mellitus (T2DM) | Phase 1 | 2025-03-08 |
| Completed | Bioequivalence Study to Compare Selexipag 400mcg Film Coated Tablets (400 mcg Selexipag) Versus Uptravi® 400mc Pulmonary Arterial Hypertension (PAH) | Phase 1 | 2025-01-09 |
| Completed | Bioequivalence Study to Compare Sacubitril and Valsartan Tablets (97mg/103mg) Versus Entresto® (Sacubitril and Chronic Heart Failure | Phase 1 | 2024-12-28 |
| Completed | Bioequivalence Study to Compare Empagliflozin + Linagliptin 25 mg/5 mg Film-coated Tablets Versus Glyxambi 25 Type 2 Diabetes Mellitus (T2DM) | Phase 1 | 2024-12-23 |
| Completed | Single Dose Oral Bioequivalence Study of Bempedoic Acid 180 mg Film Coated Tablet and Nilemdo® (Bempedoic Acid Hypercholesterolaemia, Mixed Dyslipidaemia, Cardiovascular Diseases | Phase 1 | 2024-12-04 |
| Completed | To Compare and Evaluate the Oral Bioavailability of Edoxaban 60 mg Film Coated Tablet With That of Lixiana® 60 Prevention of Stroke or Systemic Embolism, Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE) | N/A | 2024-08-30 |
| Completed | Bioequivalence Study of Two Products of Tenofovir Alafenamide 25 mg Film Tablet in Healthy, Adult, Human Subje Chronic Hepatitis B in Adults and Paediatric Patients | Phase 1 | 2024-07-06 |
| Completed | Macitentan and Tadalafil Film-coated Tablets 10 mg/40 mg and 'PrOpsynvi®' Macitentan and Tadalafil Film-coated PAH | Phase 1 | 2024-05-14 |
| Completed | Bioequivalence Study of Macitentan and Tadalafil Film-coated Tablets 10 Mg/40 Mg and 'PrOpsynvi®' Macitentan a PAH | Phase 1 | 2024-05-10 |
| Completed | Bioequivalence Study to Compare Bosentan 32 mg Dispersible Tablets Versus Tracleer® 32 mg Tablets Pulmonary Arterial Hypertension | Phase 1 | 2024-04-21 |
| Completed | Bioequivalence Study of Ivermectin 1% Cream and Soolantra (Ivermectin) 10 mg/g Cream Rosacea | Phase 1 | 2024-03-06 |
| Completed | Bioequivalence Study of Pimavanserin 34 mg Capsule Parkinson Disease Psychosis | Phase 1 | 2024-01-11 |
| Completed | Bioequivalence Study to Compare Empagliflozin/ Metformin HCl 12.5mg/1000mg Film-coated Tablets Type2diabetes | Phase 1 | 2024-01-04 |
| Completed | Bioequivalence Study to Compare Dolutegravir 50mg Film-coated Tablets HIV Infections | Phase 1 | 2024-01-03 |
| Completed | Bioequivalence Study of Perampanel Tablets 10 mg Epilepsy | Phase 1 | 2023-11-22 |
| Completed | Bioequivalence Study of Perampanel Tablets 12 mg Epilepsy | Phase 1 | 2023-09-14 |
| Completed | Bioequivalence Study to Compare Ibuprofen/ Paracetamol Tablets (200mg Ibuprofen/ 500mg Paracetamol) Versus Nur Migraine, Headache, Backache | Phase 1 | 2023-08-29 |
| Completed | Bioequivalence Study of Empagliflozin 25 mg Film Coated Tablets of Humanis, Turkey and Jardiance (Empagliflozi Type2 Diabetes Mellitus | Phase 1 | 2023-07-30 |
| Completed | Bioequivalence Study of Azelastine Hydrochloride/ Fluticasone Propionate 137 Microgram/50 Microgram Nasal Spra Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis | Phase 1 | 2023-03-24 |
| Completed | Bioequivalence Study of Riociguat 2.5 mg Film Coated Tablets and Adempas (Riociguat) 2.5 mg Film Coated Tablet Pulmonary Arterial Hypertension | Phase 1 | 2023-03-07 |
| Completed | Bioequivalence Study of Two Products of Apixaban 5mg Tablets in Healthy, Adult, Human Subjects Antithrombic Drug | Phase 1 | 2023-02-23 |
| Completed | Bioequivalence Study of Two Products of Apremilast 30 mg Tablets in Healthy, Adult, Human Subjects Psoriasis and Psoriatic Arthritis | Phase 3 | 2023-02-15 |
| Completed | Bioequivalence Study to Compare Chenodeoxycholic Acid Capsules (250mg Chenodeoxycholic Acid) Versus Chenodeoxy Cerebrotendinous Xanthomatoses | Phase 1 | 2022-06-12 |
| Completed | To Investigate Drug-drug Interaction and Relative Bioavailability Between the FDC AzelastineHCL/Beclomethasone Seasonal Allergic Rhinitis | Phase 1 / Phase 2 | 2021-03-25 |
| Completed | Bioequivalence Study to Compare Two Tablets of Ivermectin Tablets (3 mg Ivermectin) Versus Two Tablets of Stro Anthelmintic Agent | Phase 1 | 2020-11-19 |
| Completed | Bioequivalence Study to Compare Diclofenac Potassium Coated Tablet Versus Cataflam® 50 Coated Tablet Non-steroidal Anti-inflammatory (NSAID), Analgesic, Antipyretic | Phase 1 / Phase 2 | 2020-08-25 |
| Completed | Bioequivalence Study of Feniramidol HCl 400 mg Film Tablet (Pharmactive, Turkey) Under Fed Conditions Bioequivalence | Phase 1 | 2019-06-26 |